相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras
Michael J. Cavnar et al.
ANNALS OF SURGERY (2021)
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST)
Mazen A. Atiq et al.
MODERN PATHOLOGY (2021)
MEK inhibitors in RASopathies
Christina Bergqvist et al.
CURRENT OPINION IN ONCOLOGY (2021)
Comprehensive targeted next-generation sequencing approach in the molecular diagnosis of gastrointestinal stromal tumor
Isabelle Vanden Bempt et al.
GENES CHROMOSOMES & CANCER (2021)
Identification and Therapeutic Targeting of GPR20, Selectively Expressed in Gastrointestinal Stromal Tumors, with DS-6157a, a First-in-Class Antibody-Drug Conjugate
Kenji Iida et al.
CANCER DISCOVERY (2021)
Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy
Nikolaos Vassos et al.
CANCERS (2021)
Gastrointestinal stromal tumours
Jean-Yves Blay et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Randomized, double-blind, placebo (PL)-controlled, phase III trial of pimitespib (TAS-116), an oral inhibitor of heat shock protein 90 (HSP90), in patients (pts) with advanced gastrointestinal stromal tumor (GIST) refractory to imatinib (IM), sunitinib (SU) and regorafenib (REG).
Yoshitaka Honma et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
A multivariate prediction model for high malignancy potential gastric GI stromal tumors before endoscopic resection
Ze Yang et al.
GASTROINTESTINAL ENDOSCOPY (2020)
Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
David S. Hong et al.
LANCET ONCOLOGY (2020)
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials
Robert C. Doebele et al.
LANCET ONCOLOGY (2020)
Endoscopic submucosal excavation and endoscopic full-thickness resection for gastric schwannoma: five-year experience from a large tertiary center in China
Ya-qi Zhai et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2020)
Clinicopathologic characteristics, diagnostic clues, and prognoses of patients with multiple sporadic gastrointestinal stromal tumors: a case series and review of the literature
Yan-Ying Shen et al.
DIAGNOSTIC PATHOLOGY (2020)
Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study
Chaoyong Shen et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors An Analysis of a Randomized Clinical Trial After 10-Year Follow-up
Heikki Joensuu et al.
JAMA ONCOLOGY (2020)
Clinical course of suspected small gastrointestinal stromal tumors in the stomach
Lian-Song Ye et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2020)
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Jean-Yves Blay et al.
LANCET ONCOLOGY (2020)
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
Michael C Heinrich et al.
LANCET ONCOLOGY (2020)
EUS and EUS-guided FNA/core biopsies in the evaluation of subepithelial lesions of the lower gastrointestinal tract: 10-year experience
Irina M. Cazacu et al.
ENDOSCOPIC ULTRASOUND (2020)
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G. D. Demetri et al.
ANNALS OF ONCOLOGY (2020)
Defining Tumor Rupture in Gastrointestinal Stromal Tumor
Toshirou Nishida et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Cesar Serrano et al.
BRITISH JOURNAL OF CANCER (2019)
Mucosal incision-assisted biopsy versus endoscopic ultrasound-guided fine-needle aspiration with a rapid on-site evaluation for gastric subepithelial lesions: A randomized cross-over study
Takashi Osoegawa et al.
DIGESTIVE ENDOSCOPY (2019)
Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
Shang-Yu Wang et al.
CANCERS (2019)
CT Versus Endoscopic Ultrasound for Differentiating Small (2-5 cm) Gastrointestinal Stromal Tumors From Leiomyomas
Cheal Wung Huh et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
Bryan D. Smith et al.
CANCER CELL (2019)
Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial
Toshihiko Doi et al.
EUROPEAN JOURNAL OF CANCER (2019)
Endoscopic Enucleation Is Effective and Relatively Safe in Small Gastric Subepithelial Tumors Originating from Muscularis Propria
Eun Jung Ko et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Efficacy and safety of endoscopic resection for small submucosal tumors originating from the muscularis propria layer in the gastric fundus
Bing Li et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2019)
Laparoscopic endoscopic cooperative surgery (LECS) for the gastrointestinal tract: Updated indications
Naoki Hiki et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
High clinical impact and diagnostic accuracy of EUS-guided biopsy sampling of subepithelial lesions: a prospective, comparative study
Per Hedenstrom et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. G. Casali et al.
ANNALS OF ONCOLOGY (2018)
Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World
Toshirou Nishida et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study
Toto Holmebakk et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Familial PDGFRA-mutation syndrome: somatic and gastrointestinal phenotype
Paul N. Manley et al.
HUMAN PATHOLOGY (2018)
Current clinical management of gastrointestinal stromal tumor
Kazuya Akahoshi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Comparison between laparoscopic and open surgery for large gastrointestinal stromal tumors: A meta-analysis
Jian-Xin Cui et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Translational insights into gastrointestinal stromal tumor and current clinical advances
M. L. Hemming et al.
ANNALS OF ONCOLOGY (2018)
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate-or High-Risk Primary Gastrointestinal Stromal Tumor The PERSIST-5 Clinical Trial
Chandrajit P. Raut et al.
JAMA ONCOLOGY (2018)
Differential diagnosis of gastrointestinal stromal tumor by histopathology and immunohistochemistry
Seiichi Hirota
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events
Sebastian Huss et al.
HUMAN PATHOLOGY (2017)
Long-term outcomes of endoscopic submucosal dissection versus laparoscopic resection for gastric stromal tumors less than 2cm
Yan Meng et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Meta-analysis of laparoscopic vs. open resection of gastric gastrointestinal stromal tumors
Liangying Ye et al.
PLOS ONE (2017)
Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor
Benedikt Bosbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17
Chun-Nan Yeh et al.
ONCOTARGET (2017)
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
George D. Demetri et al.
Journal of the National Comprehensive Cancer Network (2017)
Surgical Pathology of Gastrointestinal Stromal Tumors: Practical Implications of Morphologic and Molecular Heterogeneity for Precision Medicine
Gregory W. Charville et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Laparoscopic surgery versus open resection in patients with gastrointestinal stromal tumors: An updated systematic review and meta-analysis
Hanchu Xiong et al.
AMERICAN JOURNAL OF SURGERY (2017)
Meta-analysis comparing laparoscopic versus open resection for gastric gastrointestinal stromal tumors larger than 5 cm
Xiao Lian et al.
BMC CANCER (2017)
Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome
Michael J. Cavnar et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Rapid On-Site Evaluation by Endosonographers during Endoscopic Ultrasonography-Guided Fine-Needle Aspiration for Diagnosis of Gastrointestinal Stromal Tumors
Takashi Tamura et al.
CLINICAL ENDOSCOPY (2017)
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
Yukinori Kurokawa et al.
BRITISH JOURNAL OF CANCER (2017)
Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I
Toshirou Nishida et al.
JOURNAL OF GASTROENTEROLOGY (2016)
Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis
Xiao-Cen Zhang et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2016)
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial
Peter Reichardt et al.
BMC CANCER (2016)
Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine
T. Holmebakk et al.
BRITISH JOURNAL OF SURGERY (2016)
Diagnostic and Treatment Strategy for Small Gastrointestinal Stromal Tumors
Toshirou Nishida et al.
CANCER (2016)
A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors
Johanna C. Bendell et al.
CANCER INVESTIGATION (2016)
Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?
Mikael Eriksson et al.
EUROPEAN JOURNAL OF CANCER (2016)
Adjuvant Imatinib for GI Stromal Tumors: When and For How Long?
Robert S. Benjamin et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Population-Based Epidemiology and Mortality of Small Malignant Gastrointestinal Stromal Tumors in the USA
Taylor M. Coe et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
FGFR1 and NTRK3 actionable alterations in Wild-Type gastrointestinal stromal tumors
Eileen Shi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Asian Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Stromal Tumor
Dong-Hoe Koo et al.
CANCER RESEARCH AND TREATMENT (2016)
Laparoscopic endoscopic cooperative surgery
Naoki Hiki et al.
DIGESTIVE ENDOSCOPY (2015)
Risk of progression for incidental small subepithelial tumors in the upper gastrointestinal tract
Ji Hyun Song et al.
ENDOSCOPY (2015)
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas
Paolo G. Casali et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
KIT and PDGFRA Mutations and the Risk of GI Stromal Tumor Recurrence
Heikki Joensuu et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Key Issues in the Clinical Management of Gastrointestinal Stromal Tumors: An Expert Discussion
Robert G. Maki et al.
ONCOLOGIST (2015)
Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update
Brian P. Rubin et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)
Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy
Yoshitomo Yanagimoto et al.
GASTRIC CANCER (2015)
Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors
Toshirou Nishida et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Gastrointestinal Stromal Tumors, Version 2.2014
Margaret von Mehren et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Gastrointestinal stromal tumors: what do we know now?
Christopher L. Corless
MODERN PATHOLOGY (2014)
A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
Andrew J. Wagner et al.
CLINICAL CANCER RESEARCH (2013)
Gastrointestinal Stromal Tumors Risk Assessment and Adjuvant Therapy
Heikki Joensuu
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Gastrointestinal stromal tumour
Heikki Joensuu et al.
LANCET (2013)
BRAF Mutant Gastrointestinal Stromal Tumor: First report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance
G. S. Falchook et al.
ONCOTARGET (2013)
Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
Dian Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Safety and efficacy of image-guided percutaneous biopsies in the diagnosis of gastrointestinal stromal tumors
Chih-Hua Yeh et al.
CLINICAL IMAGING (2012)
Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial
Suzanne George et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence
Martin D. McCarter et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
Heikki Joensuu et al.
LANCET ONCOLOGY (2012)
Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline
J. -M. Dumonceau et al.
ENDOSCOPY (2011)
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations
Katherine A. Janeway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gastrointestinal stromal tumours: origin and molecular oncology
Christopher L. Corless et al.
NATURE REVIEWS CANCER (2011)
Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size
Sabrina Rossi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
Ping Chi et al.
NATURE (2010)
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
Jason S. Gold et al.
LANCET ONCOLOGY (2009)
Microscopic gastrointestinal stromal tumors in Esophageal and intestinal surgical resection specimens -: A clinicopothologic, immunohistochemical, and molecular study of 19 lesions
Abbas Agaimy et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors
Narasimhan P. Agaram et al.
GENES CHROMOSOMES & CANCER (2008)
Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version
Toshirou Nishida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
Michael C. Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD
Barbara Pasini et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
Seedling mesenchymal tumors (Gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction
Susan C. Abraham et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Site-dependent differential KIT and PDGFRA expression in gastric and intestinal gastrointestinal stromal tumors
Florian Haller et al.
MODERN PATHOLOGY (2007)
Multicentric sporadic gastrointestinal stromal tumors (GISTs) of the stomach with distinct clonal origin:: Differential diagnosis to familial and syndromal GIST variants and peritoneal metastasis
Florian Haller et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
High incidence of microscopic gastrointestinal stromal tumors in the stomach
Kaori Kawanowa et al.
HUMAN PATHOLOGY (2006)
Gastrointestinal stromal tumors: Pathology and prognosis at different sites
Markku Miettinen et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2006)
Differential expression of connexin 43 in gastrointestinal stromal tumours of gastric and small intestinal origin
A Nishitani et al.
JOURNAL OF PATHOLOGY (2005)
Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study
RK Yantiss et al.
MODERN PATHOLOGY (2005)
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor
A Chompret et al.
GASTROENTEROLOGY (2004)
PDGFRA activating mutations in gastrointestinal stromal tumors
MC Heinrich et al.
SCIENCE (2003)
Diagnosis of gastrointestinal stromal tumors: A consensus approach
CDM Fletcher et al.
HUMAN PATHOLOGY (2002)
KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size
CL Corless et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
